United States vs Fidalgis Font
In a significant victory for the defense, attorney Marc Seitles successfully represented Fidalgis Font, the CEO of Tellus Clinical Research, in a medical fraud case involving alleged “fake” clinical drug trials. Font was acquitted of all federal charges including conspiracy, wire fraud, mail fraud and money laundering brought by the Department of Justice. Seitles argued that Font, as the clinic… Read More